Unlock stock picks and a broker-level newsfeed that powers Wall Street.
editorial-team@simplywallst.com (Simply Wall St)
4 min read
In This Article:
Amidst economic uncertainty and inflation fears, global markets have been under pressure, with U.S. stock indexes declining due to trade policy concerns and persistent inflation impacting growth shares. In this challenging environment, identifying high-growth tech stocks that can navigate these headwinds is crucial for investors seeking potential opportunities in the tech sector.
Name |
Revenue Growth |
Earnings Growth |
Growth Rating |
---|---|---|---|
eWeLLLtd |
24.65% |
25.30% |
★★★★★★ |
Pharma Mar |
24.24% |
40.82% |
★★★★★★ |
Seojin SystemLtd |
31.68% |
39.34% |
★★★★★★ |
Elicera Therapeutics |
63.53% |
97.24% |
★★★★★★ |
Elliptic Laboratories |
49.76% |
88.21% |
★★★★★★ |
Ascelia Pharma |
46.09% |
66.93% |
★★★★★★ |
CD Projekt |
33.68% |
36.76% |
★★★★★★ |
JNTC |
28.84% |
104.08% |
★★★★★★ |
Ascentage Pharma Group International |
23.93% |
83.57% |
★★★★★★ |
Delton Technology (Guangzhou) |
20.25% |
29.52% |
★★★★★★ |
Let’s explore several standout options from the results in the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Sangfor Technologies Inc. offers IT infrastructure solutions both in China and globally, with a market capitalization of CN¥42.97 billion.
Operations: Sangfor Technologies Inc. specializes in IT infrastructure solutions, serving both domestic and international markets. The company’s revenue streams are primarily derived from its comprehensive range of products and services designed to enhance IT efficiency and security.
Sangfor Technologies has demonstrated resilience with a reported annual revenue of CNY 7.52 billion, slightly down from CNY 7.66 billion the previous year, yet maintaining consistent earnings per share at CNY 0.47. The firm’s commitment to innovation is evident in its strategic allocation of funds towards share repurchases valued at CNY 200 million, aimed at bolstering employee ownership plans—a move that underscores confidence in its operational stability and future growth prospects. Additionally, Sangfor’s projected earnings growth rate of 28.9% annually outpaces the broader Chinese market’s forecast of 24.8%, signaling robust potential despite a highly volatile share price in recent months.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Empyrean Technology Co., Ltd. specializes in the development, sale, and servicing of electronic design automation (EDA) software and has a market capitalization of CN¥60.55 billion.